dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiska medel - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiska medel - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
betahistin ebb 16 mg tablett
ebb medical ab - betahistindihydroklorid - tablett - 16 mg - betahistindihydroklorid 16 mg aktiv substans; laktosmonohydrat hjälpämne
betahistin ebb 8 mg tablett
ebb medical ab - betahistindihydroklorid - tablett - 8 mg - betahistindihydroklorid 8 mg aktiv substans; laktosmonohydrat hjälpämne
betahistin ebb 16 mg tablett
ebb medical ab - betahistindihydroklorid - tablett - 16 mg - betahistindihydroklorid 16 mg aktiv substans; laktosmonohydrat hjälpämne
betahistin ebb 8 mg tablett
ebb medical ab - betahistindihydroklorid - tablett - 8 mg - betahistindihydroklorid 8 mg aktiv substans; laktosmonohydrat hjälpämne
betahistine stada 8 mg tablett
stada arzneimittel ag - betahistindihydroklorid - tablett - 8 mg - betahistindihydroklorid 8 mg aktiv substans; mannitol hjälpämne
betahistine sandoz 8 mg tablett
sandoz a/s - betahistindihydroklorid - tablett - 8 mg - betahistindihydroklorid 8 mg aktiv substans; laktosmonohydrat hjälpämne
betahistine sandoz 16 mg tablett
sandoz a/s - betahistindihydroklorid - tablett - 16 mg - betahistindihydroklorid 16 mg aktiv substans; laktosmonohydrat hjälpämne
dasatinib sandoz 20 mg filmdragerad tablett
sandoz a/s - dasatinib (vattenfri) - filmdragerad tablett - 20 mg - dasatinib (vattenfri) 20 mg aktiv substans; natriumlaurilsulfat hjälpämne; laktosmonohydrat hjälpämne